Mycophenolate Mofetil for the Treatment of Autoimmune Hepatitis in Patients Refractory or Intolerant to Conventional Therapy
BACKGROUND: Autoimmune hepatitis is characterized by hepatocellular inflammation often progressing to cirrhosis. Standard treatment consists of corticosteroids and azathioprine. For the 20% of patients with refractory disease or those who are intolerant to medication, there is no standardized treatm...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2010-01-01
|
| Series: | Canadian Journal of Gastroenterology |
| Online Access: | http://dx.doi.org/10.1155/2010/891252 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832554650929201152 |
|---|---|
| author | Kaveh Sharzehi Mary Ann Huang Ian R Schreibman Kimberly A Brown |
| author_facet | Kaveh Sharzehi Mary Ann Huang Ian R Schreibman Kimberly A Brown |
| author_sort | Kaveh Sharzehi |
| collection | DOAJ |
| description | BACKGROUND: Autoimmune hepatitis is characterized by hepatocellular inflammation often progressing to cirrhosis. Standard treatment consists of corticosteroids and azathioprine. For the 20% of patients with refractory disease or those who are intolerant to medication, there is no standardized treatment. |
| format | Article |
| id | doaj-art-994b716e33364e1dbf101ac7d1af9ef1 |
| institution | Kabale University |
| issn | 0835-7900 |
| language | English |
| publishDate | 2010-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Journal of Gastroenterology |
| spelling | doaj-art-994b716e33364e1dbf101ac7d1af9ef12025-02-03T05:50:57ZengWileyCanadian Journal of Gastroenterology0835-79002010-01-01241058859210.1155/2010/891252Mycophenolate Mofetil for the Treatment of Autoimmune Hepatitis in Patients Refractory or Intolerant to Conventional TherapyKaveh Sharzehi0Mary Ann Huang1Ian R Schreibman2Kimberly A Brown3Division of Gastroenterology and Hepatology, Penn State Milton S Hershey Medical Center, Hershey, Pennsylvania, USADivision of Gastroenterology and Hepatology, Henry Ford Hospital, Detroit, Michigan, USADivision of Gastroenterology and Hepatology, Penn State Milton S Hershey Medical Center, Hershey, Pennsylvania, USADivision of Gastroenterology and Hepatology, Henry Ford Hospital, Detroit, Michigan, USABACKGROUND: Autoimmune hepatitis is characterized by hepatocellular inflammation often progressing to cirrhosis. Standard treatment consists of corticosteroids and azathioprine. For the 20% of patients with refractory disease or those who are intolerant to medication, there is no standardized treatment.http://dx.doi.org/10.1155/2010/891252 |
| spellingShingle | Kaveh Sharzehi Mary Ann Huang Ian R Schreibman Kimberly A Brown Mycophenolate Mofetil for the Treatment of Autoimmune Hepatitis in Patients Refractory or Intolerant to Conventional Therapy Canadian Journal of Gastroenterology |
| title | Mycophenolate Mofetil for the Treatment of Autoimmune Hepatitis in Patients Refractory or Intolerant to Conventional Therapy |
| title_full | Mycophenolate Mofetil for the Treatment of Autoimmune Hepatitis in Patients Refractory or Intolerant to Conventional Therapy |
| title_fullStr | Mycophenolate Mofetil for the Treatment of Autoimmune Hepatitis in Patients Refractory or Intolerant to Conventional Therapy |
| title_full_unstemmed | Mycophenolate Mofetil for the Treatment of Autoimmune Hepatitis in Patients Refractory or Intolerant to Conventional Therapy |
| title_short | Mycophenolate Mofetil for the Treatment of Autoimmune Hepatitis in Patients Refractory or Intolerant to Conventional Therapy |
| title_sort | mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory or intolerant to conventional therapy |
| url | http://dx.doi.org/10.1155/2010/891252 |
| work_keys_str_mv | AT kavehsharzehi mycophenolatemofetilforthetreatmentofautoimmunehepatitisinpatientsrefractoryorintoleranttoconventionaltherapy AT maryannhuang mycophenolatemofetilforthetreatmentofautoimmunehepatitisinpatientsrefractoryorintoleranttoconventionaltherapy AT ianrschreibman mycophenolatemofetilforthetreatmentofautoimmunehepatitisinpatientsrefractoryorintoleranttoconventionaltherapy AT kimberlyabrown mycophenolatemofetilforthetreatmentofautoimmunehepatitisinpatientsrefractoryorintoleranttoconventionaltherapy |